期刊文献+

降酶口服液对慢性乙型肝炎的治疗作用 被引量:1

Therapeutic effect Jiangmei drink on chrnic hepatitis B
下载PDF
导出
摘要 目的:观察降酶口服液对慢性乙型肝炎的治疗作用,并探究其作用机制。方法:慢性乙型肝炎264例,随机分为两组,治疗组(184例)和对照组(80例)患者分别给予降酶口服液和护肝胶囊治疗2个月,观察治疗前后两组患者的肝功能(ALT、AST、TBil、PT、A/G)及肝脏病理组织学改变。结果:临床总有效率治疗组为89·1%,对照组为78·8%,两组比较差异有显著性意义(P<0·05)。治疗后治疗组患者肝功能明显改善,19例患者行肝活检证实肝脏炎症活动度明显减轻,肝纤维化也有一定程度改善。结论:降酶口服液对慢性乙型肝炎有较好的临床疗效。 Objective: To observe the therapeutic effect of Jiangrnei Drink on chronic hepatitis B. Methods: Two hundred and sixty lout cases of chronic hepatitis B were randomly divided into 2 groups. The treatmen group ( 184 cases) and the con- trol group (80 cases) were, respectively, given Jiangmei drink and Hugan capsules for 2 months. Then their liver functions (ALT, AST, TBil, PT, A/G) before and after the treatment and the pathogenic histological changes in the liver were observed. Results: The total effective rate in the treatment group was 89.1% while 78.8% in the control group. There was significant difference between them (P〈 0.05) ; After treatment, the liver function of the treatment group was improved remarkably, In 19 cases, the biopsy of liver tissue showed that the activity of the inflammation was relieved, The liver fibrosis was also improved to a certain degree, It can also protect the liver from fat degeneration and necrosis, Conclusion: Jiangmei drink has protective function on patients with chronic hepatitis B.
出处 《中西医结合肝病杂志》 CAS 2006年第2期71-72,共2页 Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases
基金 济宁市科研计划课题(No.200143)
关键词 降酶口服液/治疗应用 肝炎 乙型 慢性 肝功能 肝脏活组织学检查 Jiangmei drink/therapeutic use chronic hepatitis B liver function biopsy of liver
  • 相关文献

参考文献5

二级参考文献9

  • 1尤丽芬,中国免疫学杂志,1990年,6卷,60页
  • 2甘立宪,有机化学,1986年,1期,37页
  • 3曹正中,化学学报,1985年,43卷,581页
  • 4张生昌,吉林医学院学报,1985年,1期,1页
  • 5刘耕陶,1985年
  • 6张银娣,药学学报,1984年,19卷,619页
  • 7闵贤,江苏医药,1977年,10期,6页
  • 8团体著者,实用临床检验,1965年
  • 9Paolo Fabris,Franco Marranconi,Loredana Bozzola,Maria Raffaella Biasin,Franca De Lazzari,Mario Plebani,Paolo Benedetti,Giulia Tositti,Gianpietro Pellizzer,Clara Stecca,Fausto de Lalla. Fibrogenesis serum markers in patients with chronic hepatitis C treated with α-IFN[J] 1999,Journal of Gastroenterology(3):345~350

共引文献1321

同被引文献40

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部